• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔黏膜芬太尼枸橼酸盐含片滥用导致猖獗性龋齿。

Rampant caries from oral transmucosal fentanyl citrate lozenge abuse.

机构信息

Salivary Gland Center, Columbia University College of Dental Medicine, 630 West 168th St., New York, NY, USA.

出版信息

J Am Dent Assoc. 2011 Apr;142(4):406-9. doi: 10.14219/jada.archive.2011.0195.

DOI:10.14219/jada.archive.2011.0195
PMID:21454846
Abstract

BACKGROUND

Oral transmucosal fentanyl citrate lozenges (lollipops) are indicated for the oral management of breakthrough cancer pain. When abused, these sucrose-containing lozenges can cause rampant dental caries.

CASE DESCRIPTION

The authors examined a 19-year-old man whose dentist referred him because of total dental coronal destruction. After the authors questioned the patient, they concluded that his frequent oral use of sucrose-containing opioid fentanyl citrate lozenges across a three-year period caused the dental condition.

CLINICAL IMPLICATIONS

Dentists should be aware that oral transmucosal fentanyl citrate lozenges are being prescribed off-label for the control of pain from nonmalignant sources. Fentanyl citrate's effective analgesic potency can lead to misuse and potential abuse. Early recognition of its misuse could prevent severe dental caries and the need for extensive dental restoration.

摘要

背景

枸橼酸芬太尼口含舌下片(棒棒糖)用于口服管理突破性癌痛。当被滥用时,这些含蔗糖的棒棒糖会导致猖獗的龋齿。

病例描述

作者检查了一名 19 岁的男子,他的牙医因全冠牙冠破坏将他转介过来。在询问了患者之后,作者们得出结论,他在三年内频繁地使用含蔗糖的阿片类药物枸橼酸芬太尼口含舌下片导致了这种口腔状况。

临床意义

牙医应该意识到,枸橼酸芬太尼口含舌下片正在被超说明书用于控制非恶性来源的疼痛。芬太尼的有效镇痛效力可能导致误用和潜在滥用。早期识别其误用可以预防严重的龋齿和广泛的牙齿修复需求。

相似文献

1
Rampant caries from oral transmucosal fentanyl citrate lozenge abuse.口腔黏膜芬太尼枸橼酸盐含片滥用导致猖獗性龋齿。
J Am Dent Assoc. 2011 Apr;142(4):406-9. doi: 10.14219/jada.archive.2011.0195.
2
The sugar-loaded fentanyl lollipop (Actiq) and the risk for tooth decay.含糖芬太尼棒棒糖(阿片控释口溶膜)与龋齿风险
Gen Dent. 2011 May-Jun;59(3):168-70.
3
A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.一项关于新型枸橼酸芬太尼舌下制剂(芬太尼乙基制药)用于阿片类药物治疗的癌症患者爆发性疼痛的随机、安慰剂对照研究。
Clin Ther. 2014 Mar 1;36(3):357-67. doi: 10.1016/j.clinthera.2014.01.006. Epub 2014 Feb 5.
4
Fentanyl buccal tablet: in breakthrough pain in opioid-tolerant patients with cancer.芬太尼口腔崩解片:用于癌症阿片耐受患者的爆发性疼痛。
Drugs. 2006;66(18):2387-93; discussion 2394-5. doi: 10.2165/00003495-200666180-00013.
5
Emerging opioid abuse in terminal cancer patients taking oral transmucosal fentanyl citrate for breakthrough pain.在使用口服黏膜芬太尼柠檬酸盐治疗爆发性疼痛的晚期癌症患者中出现的阿片类药物滥用问题。
J Pain Symptom Manage. 2011 Dec;42(6):e6-8. doi: 10.1016/j.jpainsymman.2011.07.006. Epub 2011 Nov 1.
6
Fentanyl buccal tablet.芬太尼口腔崩解片
Drugs Today (Barc). 2008 Jan;44(1):41-54. doi: 10.1358/dot.2008.44.1.1178469.
7
Oral transmucosal fentanyl: new preparation. For breakthrough cancer pain when morphine fails.口腔黏膜芬太尼:新制剂。用于吗啡治疗无效时的癌症突破性疼痛。
Prescrire Int. 2002 Aug;11(60):106-7.
8
Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.芬太尼泡腾颊片(FEBT)1080微克与口腔黏膜枸橼酸芬太尼1600微克的相对生物利用度以及FEBT 270至1300微克的剂量比例:一项在健康成年志愿者中进行的单剂量、随机、开放标签、三周期研究。
Clin Ther. 2006 May;28(5):715-24. doi: 10.1016/j.clinthera.2006.05.016.
9
Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo-controlled trial for treatment of breakthrough pain in cancer patients.口腔黏膜枸橼酸芬太尼:用于治疗癌症患者爆发性疼痛的随机、双盲、安慰剂对照试验。
J Natl Cancer Inst. 1998 Apr 15;90(8):611-6. doi: 10.1093/jnci/90.8.611.
10
Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.口服黏膜用枸橼酸芬太尼用于治疗使用透皮芬太尼治疗持续性疼痛的癌症患者爆发性疼痛的剂量滴定多中心研究。
J Clin Oncol. 1998 Oct;16(10):3238-45. doi: 10.1200/JCO.1998.16.10.3238.

引用本文的文献

1
Improvement of Pain Relief of Fentanyl Citrate Drug Encapsulated in Nanostructured Lipid Carrier: Drug Formulation, Parameter Optimization, in vitro and in vivo Studies.枸橼酸芬太尼包封于纳米结构脂质载体中缓解疼痛的效果改善:药物制剂、参数优化、体外和体内研究。
Drug Des Devel Ther. 2020 May 25;14:2033-2045. doi: 10.2147/DDDT.S235474. eCollection 2020.
2
Micromonas micros: A rare anaerobic cause of late implant failure following spinal surgery.微拟球藻(Micromonas micros):脊柱手术后晚期种植体失败的罕见厌氧病因。
J Spinal Cord Med. 2022 Mar;45(2):311-315. doi: 10.1080/10790268.2019.1677984. Epub 2019 Oct 30.
3
Fentanyl Formulations in the Management of Pain: An Update.
芬太尼制剂在疼痛管理中的应用:更新。
Drugs. 2017 May;77(7):747-763. doi: 10.1007/s40265-017-0727-z.
4
Fentanyl for the treatment of tumor-related breakthrough pain.芬太尼治疗肿瘤相关性爆发痛。
Dtsch Arztebl Int. 2013 Apr;110(16):271-7. doi: 10.3238/arztebl.2013.0271. Epub 2013 Apr 19.